References
1. Anteby EY, Yagel S, Hanoch J, Shapiro M, Moses AE. Puerperal
and intrapartum group A streptococcal infection. Infect Dis Obstet
Gynecol 1999;7(6):276-82.
2. O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig
A, et al. The epidemiology of invasive group A streptococcal infection
and potential vaccine implications: United States, 2000-2004. Clin
Infect Dis 2007;45(7):853-62.
3. Tanaka H, Katsuragi S, Hasegawa J, Tanaka K, Osato K, Nakata M, et
al. The most common causative bacteria in maternal sepsis-related deaths
in Japan were group A Streptococcus: A nationwide survey. J Infect
Chemother 2019;25(1):41-4.
4. Schuitemaker N, van Roosmalen J, Dekker G, van Dongen P, van Geijn H,
Gravenhorst JB. Increased maternal mortality in The Netherlands from
group A streptococcal infections. Eur J Obstet Gynecol Reprod Biol
1998;76(1):61-4.
5. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis
of causes of maternal death: a systematic review. Lancet
2006;367(9516):1066-74.
6. Gustafson LW, Blaakær J, Helmig RB. Group A streptococci infection. A
systematic clinical review exemplified by cases from an obstetric
department. Eur J Obstet Gynecol Reprod Biol 2017;215:33-40.
7. Hamilton SM, Stevens DL, Bryant AE. Pregnancy-related group a
streptococcal infections: temporal relationships between bacterial
acquisition, infection onset, clinical findings, and outcome. Clin
Infect Dis 2013;57(6):870-6.
8. Rottenstreich A, Benenson S, Levin G, Kleinstern G, Moses AE, Amit S.
Risk factors, clinical course and outcomes of pregnancy-related group A
streptococcal infections: retrospective 13-year cohort study. Clin
Microbiol Infect. 2019;25(2):251.e1-.e4.
9. Leonard A, Wright A, Saavedra-Campos M, Lamagni T, Cordery R,
Nicholls M, et al. Severe group A streptococcal infections in mothers
and their newborns in London and the South East, 2010-2016: assessment
of risk and audit of public health management. BJOG 2019;126(1):44-53.
10. Tuuli MG, Liu L, Longman RE, Odibo AO, Macones GA, Cahill AG.
Infectious morbidity is higher after second-stage compared with
first-stage cesareans. Am J Obstet Gynecol 2014;211(4):410.e1-6.
11. Rimawi BH, Soper DE, Eschenbach DA. Group A streptococcal infections
in obstetrics and gynecology. Clin Obstet Gynecol 2012;55(4):864-74.
12. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey
RD, et al. Antibiotic therapy for reduction of infant morbidity after
preterm premature rupture of the membranes. A randomized controlled
trial. National Institute of Child Health and Human Development
Maternal-Fetal Medicine Units Network. JAMA 1997;278(12):989-95.
13. Atalić B. Uz 200. obljetnicu rođenja Ignaza Philippa Semmelweisa
[200th birth anniversary of Ignatius Philipp Semmelweis]. Acta Med
Hist Adriat. 2018 Jun;16(1):9-18. Croatian. PMID: 30198270.
14. Shinar S, Fouks Y, Amit S, Pauzner D, Tarabeia J, Schechner V, Many
A. Clinical Characteristics of and Preventative Strategies for
Peripartum Group A Streptococcal Infections. Obstet Gynecol. 2016
Feb;127(2):227-32. doi: 10.1097/AOG.0000000000001238. PMID: 26942347.
15. Olafsdottir LB, Erlendsdóttir H, Melo-Cristino J, Weinberger DM,
Ramirez M, Kristinsson KG, Gottfredsson M. Invasive infections due to
Streptococcus pyogenes: seasonal variation of severity and clinical
characteristics, Iceland, 1975 to 2012. Euro Surveill. 2014 May
1;19(17):5-14. Erratum in: Euro Surveill. 2016;21(10). doi:
10.2807/1560-7917.ES.2016.21.10.30158. PMID: 24821122.